CLINICAL_TRIALS
trial_result
· 2022-10-20
Clinical Trial Update: Vonoprazan Hp Dual or Triple Eradication Regimes [Phase 4]
Summary
A Phase 4 clinical trial update evaluating vonoprazan-based dual or triple eradication regimens for Helicobacter pylori infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Helicobacter Pylori | Phase 4 | Status: UNKNOWN